<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>UNLABELLED: <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> (BE), a known precursor of esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> has recently been associated with <z:e sem="disease" ids="C0850011,C0850009" disease_type="Disease or Syndrome" abbrv="">human papillomavirus</z:e> (HPV) </plain></SENT>
<SENT sid="1" pm="."><plain>p16(INK4a) expression is a recognized surrogate marker of HPV <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> in the cervix </plain></SENT>
<SENT sid="2" pm="."><plain>OBJECTIVES: This study has assessed the possible role of <z:e sem="disease" ids="C0850011,C0850009" disease_type="Disease or Syndrome" abbrv="">human papillomavirus</z:e> (HPV) <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> in BE and esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp>, in the North American population by screening esophageal tissues for HPV by a combination of assays </plain></SENT>
<SENT sid="3" pm="."><plain>STUDY DESIGN: Formalin-fixed, paraffin-embedded blocks from cases of <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> (n=84), esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> (n=36) and <z:mpath ids='MPATH_458'>normal</z:mpath> gastro-esophageal junction (n=29) were examined for HPV by PCR, chromogenic in situ hybridization, and p16(INK4a) immunohistochemistry </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: HPV DNA was detected by PCR in 23 of 84 (27.4%) BE cases, 11 of 36 (31%) cases of <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> and in 7 of 29 (24%) <z:mpath ids='MPATH_458'>normal</z:mpath> control cases (p=0.82) </plain></SENT>
<SENT sid="5" pm="."><plain>p16(INK4a) staining was positive in 10 (12%) cases of BE, 15 (42%) cases of <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> and 6 (21%) cases of the control group </plain></SENT>
<SENT sid="6" pm="."><plain>Positive p16(INK4a) staining was not statistically different between the three groups whether positive or negative for HPV DNA (p=0.91 and p=0.91 respectively) </plain></SENT>
<SENT sid="7" pm="."><plain>Similarly, negative p16(INK4a) staining did not show a difference between the three groups for whether positive or negative for HPV DNA (p=0.50 and p=0.28, respectively) </plain></SENT>
<SENT sid="8" pm="."><plain>HPV was not detected by CISH in the <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> while in BE and control groups, CISH was non-contributory </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: These data suggest that while HPV is detectable in a subset of esophageal lesions and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e>, the HPV detected is unlikely to be of etiologic significance or a factor accounting for the increase in BE and esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> cases in the United States </plain></SENT>
</text></document>